Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Heart Failure POC & LOC Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Test Type (Genomic Testing, Metabolomic Testing, Proteomic Testing)
5.2.2. By Technology (Array-based Systems, Microfluidics)
5.2.3. By End-user (Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, Laboratory)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Product Market Map
5.3.1. By Test Type
5.3.2. By Technology
5.3.3. By End-user
5.3.4. By Region
6. North America Heart Failure POC & LOC Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test Type (Genomic Testing, Metabolomic Testing, Proteomic Testing)
6.2.2. By Technology (Array-based Systems, Microfluidics)
6.2.3. By End-user (Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, Laboratory)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Heart Failure POC & LOC Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Test Type
6.3.1.2.2. By Technology
6.3.1.2.3. By End-user
6.3.2. Canada Heart Failure POC & LOC Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Test Type
6.3.2.2.2. By Technology
6.3.2.2.3. By End-user
6.3.3. Mexico Heart Failure POC & LOC Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Test Type
6.3.3.2.2. By Technology
6.3.3.2.3. By End-user
7. Europe Heart Failure POC & LOC Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test Type (Genomic Testing, Metabolomic Testing, Proteomic Testing)
7.2.2. By Technology (Array-based Systems, Microfluidics)
7.2.3. By End-user (Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, Laboratory)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Heart Failure POC & LOC Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Test Type
7.3.1.2.2. By Technology
7.3.1.2.3. By End-user
7.3.2. United Kingdom Heart Failure POC & LOC Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Test Type
7.3.2.2.2. By Technology
7.3.2.2.3. By End-user
7.3.3. France Heart Failure POC & LOC Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Test Type
7.3.3.2.2. By Technology
7.3.3.2.3. By End-user
7.3.4. Italy Heart Failure POC & LOC Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Test Type
7.3.4.2.2. By Technology
7.3.4.2.3. By End-user
7.3.5. Spain Heart Failure POC & LOC Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Test Type
7.3.5.2.2. By Technology
7.3.5.2.3. By End-user
8. Asia-Pacific Heart Failure POC & LOC Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test Type (Genomic Testing, Metabolomic Testing, Proteomic Testing)
8.2.2. By Technology (Array-based Systems, Microfluidics)
8.2.3. By End-user (Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, Laboratory)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Heart Failure POC & LOC Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Test Type
8.3.1.2.2. By Technology
8.3.1.2.3. By End-user
8.3.2. Japan Heart Failure POC & LOC Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Test Type
8.3.2.2.2. By Technology
8.3.2.2.3. By End-user
8.3.3. India Heart Failure POC & LOC Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Test Type
8.3.3.2.2. By Technology
8.3.3.2.3. By End-user
8.3.4. Australia Heart Failure POC & LOC Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Test Type
8.3.4.2.2. By Technology
8.3.4.2.3. By End-user
8.3.5. South Korea Heart Failure POC & LOC Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Test Type
8.3.5.2.2. By Technology
8.3.5.2.3. By End-user
9. South America Heart Failure POC & LOC Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Test Type (Genomic Testing, Metabolomic Testing, Proteomic Testing)
9.2.2. By Technology (Array-based Systems, Microfluidics)
9.2.3. By End-user (Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, Laboratory)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Heart Failure POC & LOC Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Test Type
9.3.1.2.2. By Technology
9.3.1.2.3. By End-user
9.3.2. Argentina Heart Failure POC & LOC Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Test Type
9.3.2.2.2. By Technology
9.3.2.2.3. By End-user
9.3.3. Colombia Heart Failure POC & LOC Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Test Type
9.3.3.2.2. By Technology
9.3.3.2.3. By End-user
10. Middle East and Africa Heart Failure POC & LOC Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Test Type (Genomic Testing, Metabolomic Testing, Proteomic Testing)
10.2.2. By Technology (Array-based Systems, Microfluidics)
10.2.3. By End-user (Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, Laboratory)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Heart Failure POC & LOC Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Test Type
10.3.1.2.2. By Technology
10.3.1.2.3. By End-user
10.3.2. Saudi Arabia Heart Failure POC & LOC Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Test Type
10.3.2.2.2. By Technology
10.3.2.2.3. By End-user
10.3.3. UAE Heart Failure POC & LOC Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Test Type
10.3.3.2.2. By Technology
10.3.3.2.3. By End-user
10.3.4. Kuwait Heart Failure POC & LOC Devices Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Test Type
10.3.4.2.2. By Technology
10.3.4.2.3. By End-user
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Porter?s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
14.6.1. Abbott Laboratories Inc
14.6.2. Siemens Healthineers AG
14.6.3. Danaher Corp
14.6.4. Instrumentation Laboratory Co
14.6.5. Hoffmann-La Roche Ltd
14.6.6. bioMerieux Inc
14.6.7. Abaxis Inc
14.6.8. Quidel Corp
14.6.9. Jant Pharmacal Corp
14.6.10. Trinity Biotech plc
15. Strategic Recommendations
16. About Us & Disclaimer